Director, HEAD OF R&D, COO-NOVITIUM OPS · ANI PHARMACEUTICALS INC · Common Stock
Side
F
Value
$221K
Shares
2,898
Price
$76.25
Executed
Feb 11, 2026
Disclosed
Feb 13, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 11 executedFeb 13, 2026 disclosed
ANIP · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+4 / 25
$221K reported value · 3.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Shanmugam Muthusamy filed this Form 4 reporting a tax withholding of ANIP on Feb 11, 2026. It became public on Feb 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, HEAD OF R&D, COO-NOVITIUM OPS
Shanmugam Muthusamycik:0001870913
Issuer
ANI PHARMACEUTICALS INCcik:0001023024
Revision history · 0
No field has changed since this record was first ingested.
